Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -16.28x is 19% below its 3-year average of -13.66x, near the high end of its 3-year range (-469.76x–-5.42x).
50.25% below its 12-month average of -10.84x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -5.42x.
INTEREST COVERAGE RATIO
-16.28x
INTEREST COVERAGE RATIO AVG TTM
-10.84x
INTEREST COVERAGE RATIO AVG 3Y
-13.66x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-50.25%
CURRENT VS 3Y AVG
-19.21%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.87x
median of 485 covered companies
CURRENT VS SECTOR MEDIAN
-177.34%
vs the sector median at left
Milestone Pharmaceuticals Inc.
Market Cap
$97.82M
Interest Coverage Ratio
-16.28x
TTM Avg
-10.84x
3Y Avg
-13.66x
5Y Avg
N/A
Market Cap
$96.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$92.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$93.26M
Interest Coverage Ratio
2.53x
TTM Avg
4.25x
3Y Avg
3.46x
5Y Avg
3.46x
Market Cap
$102.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.54M
Interest Coverage Ratio
N/A
TTM Avg
2.91x
3Y Avg
2.91x
5Y Avg
2.91x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $97.82M | -16.28x | -10.84x | -13.66x | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.59M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $96.06M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $99.61M | -48.13x | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $92.18M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.26M | 2.53x | 4.25x | 3.46x | 3.46x |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.25M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.54M | N/A | 2.91x | 2.91x | 2.91x |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $90.16M | -22.29x | N/A | N/A | N/A |
Interest Coverage
-16.3x
Debt/Equity
7.79
Current Ratio
8.13
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -5.42x |
| 2026-03-31 | -5.75x |
| 2025-12-31 | -17.52x |
| 2025-09-30 | -12.31x |
| 2025-06-30 | -13.18x |
| 2025-03-31 | -21.95x |
| 2024-12-31 | -13.44x |
| 2024-09-30 | -10.65x |
| 2024-06-30 | -10.89x |
| 2024-03-31 | -12.01x |
| 2023-12-31 | -16.10x |
| 2023-09-30 | -18.26x |
| 2023-06-30 | -20.04x |
| 2023-03-31 | -469.76x |
